$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

COVID-19 : caractéristiques cliniques, biologiques et radiologiques chez l’adulte, la femme enceinte et l’enfant. Une mise au point au cœur de la pandémie
COVID-19: Clinical, biological and radiological characteristics in adults, infants and pregnant women. An up-to-date review at the heart of the pandemic 원문보기

La Revue de médecine interne, v.41 no.5, 2020년, pp.308 - 318  

Plaçais, L. (Mé) ,  Richier, Q. (decine interne, Sorbonne Université)

Abstract AI-Helper 아이콘AI-Helper

Abstract The spread of the new coronavirus SARS-CoV-2, discovered in China in January 2020, led to a pandemic as early as March 2020, forcing every health care system in the affected countries to adapt quickly. In order to better address this major health crisis, which has given rise to numerous sc...

Abstract

Résumé La propagation du nouveau coronavirus SARS-CoV-2, découvert en Chine en janvier 2020, a mené à une pandémie dès mars 2020, obligeant chaque système de soins des pays touchés à une adaptation rapide. Pour mieux faire face à cette crise sanitaire majeure, qui a donné lieu à de nombreuses publications scientifiques, nous avons synthétisé les principales études cliniques originales afin de faciliter la prise en charge au quotidien des patients atteints de COVID-19. Nous détaillons les premiers signes et l’évolution de la maladie ainsi que les différentes formes cliniques, y compris extra-pulmonaires, telles qu’elles sont connues au début de cette pandémie. Nous insistons sur les marqueurs cliniques, biologiques et scannographiques prédictifs de sévérité ou de mortalité. Enfin, nous discutons de l’impact de l’infection par le SARS-CoV-2 dans les populations suspectes d’être à haut risque de formes sévères.

주제어

참고문헌 (95)

  1. 1 Cui J. Li F. Shi Z.-L. Origin and evolution of pathogenic coronaviruses Nat Rev Microbiol 17 2019 181 192 30531947 

  2. 2 Ksiazek T.G. Erdman D. Goldsmith C.S. Zaki S.R. Peret T. Emery S. A novel coronavirus associated with severe acute respiratory syndrome N Engl J Med 348 20 2003 1953 1966 12690092 

  3. 3 Drosten C. Gunther S. Preiser W. van der Werf S. Brodt H.R. Becker S. Identification of a novel coronavirus in patients with severe acute respiratory syndrome N Engl J Med 348 20 2003 1967 1976 12690091 

  4. 4 Zaki A.M. van Boheemen S. Bestebroer T.M. Osterhaus A.D. Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia N Engl J Med 367 19 2012 1814 1820 23075143 

  5. 5 Wong G. Liu W. Liu Y. Zhou B. Bi Y. Gao G.F. MERS, SARS, and Ebola: The role of super-spreaders in infectious disease Cell Host Microbe 18 4 2015 398 401 26468744 

  6. 6 Guan Y. Zheng B.J. He Y.Q. Liu X.L. Zhuang Z.X. Cheung C.L. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China Science 302 5643 2003 276 278 10.1126/science.1087139 12958366 

  7. 7 Azhar E.I. El-Kafrawy S.A. Farraj S.A. Hassan A.M. Al-Saeed M.S. Hashem A.M. Evidence for camel-to-human transmission of MERS coronavirus N Engl J Med 370 26 2014 2499 2505 24896817 

  8. 8 Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med 382 8 2020 727 733 31978945 

  9. 9 Wu Y. Ho W. Huang Y. Jin D.-Y. Li S. Liu S.-L. SARS-CoV-2?is an appropriate name for the new coronavirus Lancet 395 10228 2020 949 950 

  10. 10 Li Q. Guan X. Wu P. Wang X. Zhou L. Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia N Engl J Med. 382 13 2020 1199 1207 31995857 

  11. 11 Okada P. Buathong R. Phuygun S. Thanadachakul T. Parnmen S. Wongboot W. Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020 Euro Surveill 25 8 2020 2000097 

  12. 12 Novel Coronavirus (2019-nCoV) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports Consulte le 29?mars 2020. 

  13. 13 Novel Coronavirus (2019-nCoV) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports Consulte le 12?avril 2020. 

  14. 14 COVID Reference. Kamps BS, Hoffmann C. www.CovidReference.com 

  15. 15 UpToDate.,https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19. Consulte le 10?avril 2020 

  16. 16 Literature review. Reacting 2020. https://reacting.inserm.fr/literature-review. Consulte le 11?avril 2020 

  17. 17 Guan W. Ni Z. Hu Y. Liang W. Ou C. He J. Clinical characteristics of coronavirus disease 2019?in China N Engl J Med 2020 10.1056/NEJMoa2002032 NEJMoa2002032. 

  18. 18 Lauer S.A. Grantz K.H. Bi Q. Jones F.K. Zheng Q. Meredith H.R. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application Ann Intern Med 2020 M20 M0504 10.7326/M20-0504 

  19. 19 Novel Coronavirus (2019-nCoV) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports sitrep3 

  20. 20 Liu Y. Gayle A.A. Wilder-Smith A. Rocklov J. The reproductive number of COVID-19?is higher compared to SARS coronavirus J Travel Med 27 2 2020 [taaa021] 

  21. 21 Lescure F.-X. Bouadma L. Nguyen D. Parisey M. Wicky P.-H. Behillil S. Clinical and virological data of the first cases of COVID-19?in Europe: a case series Lancet Infect Dis 2020 10.1016/S1473-3099(20)30200-0 S1473-3099(20)30200-0. 

  22. 22 Zou L. Ruan F. Huang M. Liang L. Huang H. Hong Z. SARS-CoV-2?viral load in upper respiratory specimens of infected patients N Engl J Med 382 12 2020 1177 1179 32074444 

  23. 23 To K.K.-W. Tsang O.T.-Y. Leung W.-S. Tam A.R. Wu T.-C. Lung D.C. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Lancet Infect Dis 2020 10.1016/S1473-3099(20)30196-1 [S1473-3099(20)30196-1]. 

  24. 24 Chan J.F.-W. Yuan S. Kok K.-H. To K.K.-W. Chu H. Yang J. A familial cluster of pneumonia associated with the 2019?novel coronavirus indicating person-to-person transmission: a study of a family cluster Lancet 395 10223 2020 514 523 31986261 

  25. 25 Jefferson T. Foxlee R. Del Mar C. Dooley L. Ferroni E. Hewak B. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review BMJ 339 2009 b3675 19773323 

  26. 26 Van Doremalen N. Bushmaker T. Morris D.H. Holbrook M.G. Gamble A. Williamson B.N. Aerosol and surface stability of SARS-CoV-2?as compared with SARS-CoV-1 N Engl J Med 2020 10.1056/NEJMc2004973 [NEJMc2004973] 

  27. 27 Wang X. Pan Z. Cheng Z. Association between 2019-nCoV transmission and N95?respirator use J Hosp Infect 2020 10.1016/j.jhin.2020.02.021 [published online ahead of print, 2020?Mar 3] 

  28. 28 Bartoszko J.J. Farooqi M.A.M. Alhazzani W. Loeb M. Medical masks vs N95?respirators for preventing COVID-19?in health care workers a systematic review and meta-analysis of randomized trials Influenza Other Respir Viruses 2020 10 10.1111/irv.12745 

  29. 29 Chen W. Lan Y. Yuan X. Deng X. Li Y. Cai X. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity Emerg Microbes Infect 9 1 2020 469 473 32102625 

  30. 30 Wang W. Xu Y. Gao R. Lu R. Han K. Wu G. Detection of SARS-CoV-2?in different types of clinical JAMA 2020 e203786 10.1001/jama.2020.3786 

  31. 31 Wu P. Duan F. Luo C. Liu Q. Qu X. Liang L. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China JAMA Ophthalmol 2020 e201291 10.1001/jamaophthalmol.2020.1291 

  32. 32 Mizumoto K. Kagaya K. Zarebski A. Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 Euro Surveill 25 10 2020 2000180 

  33. 33 Hu Z. Song C. Xu C. Jin G. Chen Y. Xu X. Clinical characteristics of 24?symptomatic infections with COVID-19?screened among close contacts in Nanjing, China Sci China Life Sci 2020 10 10.1007/s11427-020-1661-4 

  34. 34 Bai Y. Yao L. Wei T. Tian F. Jin D.-Y. Chen L. Presumed asymptomatic carrier transmission of COVID-19 JAMA 2020 e202565 10.1001/jama.2020.2565 

  35. 35 National Health Commission of the PRC. http://en.nhc.gov.cn/Consulte le 12?avril 2020. 

  36. 36 Zhou F. Yu T. Du R. Fan G. Liu Y. Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19?in Wuhan, China: a retrospective cohort study Lancet 395 10229 2020 1054 1062 32171076 

  37. 37 Wu C. Chen X. Cai Y. Xia J. Zhou X. Xu S. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019?pneumonia in Wuhan, China JAMA Intern Med 2020 e200994 10.1001/jamainternmed.2020.0994 

  38. 38 Grasselli G. Zangrillo A. Zanella A. Antonelli M. Cabrini L. Castelli A. Baseline characteristics outcomes of 1591?patients infected with SARS-CoV-2?admitted to ICUs of the Lombardy region, Italy JAMA 2020 e205394 10.1001/jama.2020.5394 

  39. 39 Reseau Sentinelles, France. https://websenti.u707.jussieu.fr/sentiweb/Consulte le 12?avril 2020. 

  40. 40 Arentz M. Yim E. Klaff L. Lokhandwala S. Riedo F.X. Chong M. Characteristics outcomes of 21?critically ill patients with COVID-19?in Washington State JAMA 2020 e204326 10.1001/jama.2020.4326 

  41. 41 Bhatraju P.K. Ghassemieh B.J. Nichols M. Kim R. Jerome K.R. Nalla A.K. Covid-19?in critically ill patients in the Seattle region?case series N Engl J Med 2020 10 10.1056/NEJMoa2004500 [1056] 

  42. 42 Russell T.W. Hellewell J. Jarvis C.I. van-Zandvoort K. Abbott S. Ratnayake R. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020 Euro Surveill 25 12 2020 2000256 

  43. 43 Shim E. Tariq A. Choi W. Lee Y. Chowell G. Transmission potential and severity of COVID-19?in South Korea Int J Infect Dis 93 2020 339 344 10.1016/j.ijid.2020.03.031 32198088 

  44. 44 Verity R. Okell L.C. Dorigatti I. Winskill P. Whittaker C. Imai N. Estimates of the severity of coronavirus disease 2019: a model-based analysis Lancet Infect Dis 2020 10.1016/S1473-3099(20)30243-7 [S1473-3099(20)30243-7] 

  45. 45 Novel 2019?coronavirus genome. Virological 2020. http://virological.org/t/novel-2019-coronavirus-genome/319?Consulte le 11?avril 2020. 

  46. 46 Corman V.M. Landt O. Kaiser M. Molenkamp R. Meijer A. Chu D.K. Detection of 2019?novel coronavirus (2019-nCoV) by real-time RT-PCR Euro Surveill 25 3 2020 2000045 

  47. 47 Li Y. Yao L. Li J. Chen L. Song Y. Cai Z. Stability issues of RT-PCR testing of SARS-CoV-2?for hospitalized patients clinically diagnosed with COVID-19 J Med Virol 2020 10 10.1002/jmv.25786 

  48. 48 Ai T. Yang Z. Hou H. Zhan C. Chen C. Lv W. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014?cases Radiology 2020 200642 10.1148/radiol.2020200642 32101510 

  49. 49 Petherick A. Developing antibody tests for SARS-CoV-2 Lancet 395 10230 2020 1101 1102 32247384 

  50. 50 Guo L. Ren L. Yang S. Xiao M. Chang D. Yang F. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19) Clin Infect Dis 2020 10.1093/cid/ciaa310 [ciaa310] 

  51. 51 Zhao J. Yuan Q. Wang H. Liu W. Liao X. Su Y. Antibody responses to SARS-CoV-2?in patients of novel coronavirus disease 2019 Clin Infect Dis 2020 10.1093/cid/ciaa344 [ciaa344] 

  52. 52 Wang D. Hu B. Hu C. Zhu F. Liu X. Zhang J. Clinical characteristics of 138?hospitalized patients with 2019?novel coronavirus-infected pneumonia in Wuhan, China JAMA 2020 e201585 10.1001/jama.2020.1585 

  53. 53 Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Clinical features of patients infected with 2019?novel coronavirus in Wuhan, China Lancet 395 10223 2020 497 506 10.1016/S0140-6736(20)30183-5 31986264 

  54. 54 Li Y.C. Bai W.Z. Hashikawa T. The neuroinvasive potential of SARS-CoV2?may play a role in the respiratory failure of COVID-19?patients J Med Virol 2020 10 10.25728 

  55. 55 Mao L. Jin H. Wang M. Hu Y. Chen S. He Q. Neurologic manifestations of hospitalized patients with coronavirus disease 2019?in Wuhan, China JAMA Neurol 2020 10 10.1001/jamaneurol.2020.1127 

  56. 56 Poyiadji N. Shahin G. Noujaim D. Stone M. Patel S. Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features Radiology 2020 201187 10.1148/radiol.2020201187 32228363 

  57. 57 Chen T. Wu D. Chen H. Yan W. Yang D. Chen G. Clinical characteristics of 113?deceased patients with coronavirus disease 2019: retrospective study BMJ 2020 368 10.1136/bmj.m1091 

  58. 58 Li Y.C. Bai W.Z. Hashikawa T. The neuroinvasive potential of SARS-CoV2?may play a role in the respiratory failure of COVID-19?patients J Med Virol 2020 10 10.1002/jmv.25728 

  59. 59 Alerte-anosmie-covid-19. https://www.snorl.org/category-acces-libre/category-actualites/alerte-anosmie-covid-19-20-mars-2020/Consulte le 12?avril 2020. 

  60. 60 Hwang C.S. Olfactory neuropathy in severe acute respiratory syndrome: report of A case Acta Neurol Taiwan 15 1 2006 26 28 16599281 

  61. 61 Eliezer M. Hautefort C. Hamel A.L. Sudden and complete olfactory loss function as a possible symptom of COVID-19 JAMA Otolaryngol Head Neck Surg 2020 10 10.1001/jamaoto.2020.832 [1001] 

  62. 62 Mo P. Xing Y. Xiao Y. Deng L. Zhao Q. Wang H. Clinical characteristics of refractory COVID-19?pneumonia in Wuhan, China Clin Infect Dis 2020 10.1093/cid/ciaa270 

  63. 63 Ruan Q. Yang K. Wang W. Jiang L. Song J. Clinical predictors of mortality due to COVID-19?based on an analysis of data of 150?patients from Wuhan, China Intensive Care Med 2020 1 3 10.1007/s00134-020-05991-x 

  64. 64 Doyen D. Moceri P. Ducreux D. Dellamonica J. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes Lancet 2020 

  65. 65 Wang L. Li X. Chen H. Yan S. Li D. Li Y. Coronavirus disease 19?infection does not result in acute kidney injury: an analysis of 116?hospitalized patients from Wuhan, China Am J Nephrol 2020 1 6 10.1159/000507471 

  66. 66 Chen N. Zhou M. Dong X. Qu J. Gong F. Han Y. Epidemiological and clinical characteristics of 99?cases of 2019?novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 395 10223 2020 507 513 32007143 

  67. 67 Ilias I. Zabuliene L. Hyperglycemia and the novel Covid-19?infection: Possible pathophysiologic mechanisms Med Hypotheses 139 2020 109699 10.1016/j.mehy.2020.109699 32240876 

  68. 68 CORONAVIRUS?COVID-19?Evenements SFD. https://evenements-sfd.fr/coronavirus-covid-19/. Consulte le 12-avr-2020. 

  69. 69 Mellhammar L. Linder A. Tverring J. Christensson B. Boyd J.H. Sendi P. NEWS2?is superior to qSOFA in detecting sepsis with organ dysfunction in the emergency department J Clin Med 8 8 2019 1128 

  70. 70 Tang N. Bai H. Chen X. Gong J. Li D. Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019?patients with coagulopathy J Thromb Haemost 2020 10 10.1111/jth.14817 

  71. 71 Qin C. Zhou L. Hu Z. Zhang S. Yang S. Tao Y. Dysregulation of immune response in patients with COVID-19?in Wuhan, China Clin Infect Dis 2020 10.1093/cid/ciaa248 

  72. 72 Li K. Wu J. Wu F. The clinical and chest CT features associated with severe and critical COVID-19?pneumonia Invest Radiol 2020 10 10.1097/RLI.0000000000000672 

  73. 73 Zu Z.Y. Jiang M.D. Xu P.P. Chen W. Ni Q.Q. Lu G.M. Coronavirus disease 2019 (COVID-19): a perspective from China Radiology 2020 200490 10.1148/radiol.2020200490 32083985 

  74. 74 Shi H. Han X. Jiang N. Cao Y. Alwalid O. Gu J. Radiological findings from 81?patients with COVID-19?pneumonia in Wuhan, China: a descriptive study Lancet Infect Dis 20 4 2020 425 434 32105637 

  75. 75 Poggiali E. Dacrema A. Bastoni D. Tinelli V. Demichele E. Ramos P.M. Can lung US help critical care clinicians in the early diagnosis of novel coronavirus (COVID-19) pneumonia? Radiology 2020 200847 10.1148/radiol.2020200847 

  76. 76 Yuan M. Yin W. Tao Z. Tan W. Hu Y. Association of radiologic findings with mortality of patients infected with 2019?novel coronavirus in Wuhan, China PLoS One 15 3 2020 e0230548 32191764 

  77. 77 Chen H. Guo J. Wang C. Luo F. YU X. Zhang W. Clinical characteristics and intrauterine vertical transmission potential of COVID-19?infection in nine pregnant women: a retrospective review of medical records Lancet 395 10226 2020 809 815 32151335 

  78. 78 Schwartz D.A. An analysis of 38?pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes Arch Pathol Lab Med 2020 10 10.5858/arpa.2020-0901-SA 

  79. 79 Liu Y. Chen H. Tang K. Guo Y. Clinical manifestations and outcome of SARS-CoV-2?infection during pregnancy J Infect 2020 10.1016/j.jinf.2020.02.028 

  80. 80 Zeng L. Xia S. Yuan W. Yan K. Xiao F. Shao J. Neonatal early-onset infection with SARS-CoV-2?in 33?neonates born to mothers with COVID-19?in Wuhan, China JAMA Pediatr 2020 10.1001/jamapediatrics.2020.0878 

  81. 81 Cui Y. Tian M. Huang D. Wang X. Huang Y. Fan L. A 55-day-old female infant infected with COVID 19?presenting with pneumonia, liver injury, and heart damage J Infect Dis 2020 10.1093/infdis/jiaa113 

  82. 82 Wu Z. McGoogan J.M. Characteristics of important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72?314?cases from the Chinese Center for Disease Control and Prevention JAM.A 2020 10 10.1001/jama.2020.2648 

  83. 83 Lu X. Zhang L. Du H. Zhang J. Li Y.Y. Qu J. SARS-CoV-2?Infection in children N Engl J Med 2020 10.1056/NEJMc2005073 

  84. 84 Qiu H. Wu J. Hong L. Luo Y. Song Q. Chen D. Clinical and epidemiological features of 36?children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study Lancet Infect Dis 2020 10.1016/S1473-3099(20)30198-5 

  85. 85 Cai J. Xu J. Lin D. Yang Z. Xu L. Zhenghai Q. A case series of children with 2019?novel coronavirus infection: clinical and epidemiological features Clin Infect Dis 2020 10.1093/cid/ciaa198 

  86. 86 Xia W. Shao J. Guo Y. Peng X. Li Z. Hu D. Clinical and CT features in pediatric patients with COVID-19?infection: different points from adults Pediatr Pulmonol 2020 10 10.1002/ppul.24718 

  87. 87 Sun D. Li H. Lu X.X. Xiao H. Ren J. Zhang F.R. Clinical features of severe pediatric patients with coronavirus disease 2019?in Wuhan: a single center's observational study World J Pediatr 2020 10 10.1007/s12519-020-00354-4 

  88. 88 Wei M. Yuan J. Liu Y. Fu T. Yu X. Zhang Z.J. Novel coronavirus infection in hospitalized infants under 1?year of age in China JAMA 323 13 2020 1313 1314 10.1001/jama.2020.2131 

  89. 89 D’Antiga L. Coronaviruses immunosuppressed patients. The facts during the third epidemic Liver Transpl 2020 10 10.1002/lt.25756 

  90. 90 Gandolfini I. Delsante M. Fiaccadori E. Zaza G. Manenti L. Degli Antoni A. COVID-19?in kidney transplant recipients Am J Transplant 2020 10 10.1111/ajt.15891 31561273 

  91. 91 Monti S. Balduzzi S. Delvino P. Bellis E. Quadrelli V.S. Montecucco C. Clinical course of COVID-19?in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies Ann Rheum Dis 2020 

  92. 92 EULAR - COVID-19?Database. https://www.eular.org/eular_covid19_database.cfm. Consulte le 13?avril 2020. 

  93. 93 Liang W. Guan W. Chen R. Wang W. Li J. Xu K. Cancer patients in SARS-CoV-2?infection: a nationwide analysis in China Lancet Oncol 21 3 2020 335 337 32066541 

  94. 94 Zhang L. Zhu F. Xie L. Wang C. Wang J. Chen R. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China Ann Oncol 2020 S0923 S7534 10.1016/j.annonc.2020.03.296 

  95. 95 You B. Ravaud A. Canivet A. Giraud P. Guimbaud R. Kaluzinski The official French guidelines to protect patients with cancer against SARS-CoV-2?infection Lancet Oncol 2020 10.1016/S1470-2045(20)30204-7 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로